Skip to main content
Erschienen in: Strahlentherapie und Onkologie 6/2014

01.06.2014 | Original article

Planning study to compare dynamic and rapid arc techniques for postprostatectomy radiotherapy of prostate cancer

verfasst von: Dr. R. Cambria, M.Sc., F. Cattani, B.A. Jereczek-Fossa, F. Pansini, D. Ciardo, S. Vigorito, S. Russo, D. Zerini, L. Cozzi, R. Orecchia

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare our standard technique for postprostatectomy radiotherapy of prostate cancer, i.e. using two lateral conformal dynamic arcs with volumetric-modulated arc therapy (VMAT) performed with the RapidArc® (Varian Medical Systems, Palo Alto, CA, USA). The plans were referred to as DA and RA, respectively.

Materials and methods

The treatment plans of 44 patients receiving adjuvant/salvage radiotherapy in the first months of 2010 were compared. In all cases, the prescribed total dose was 66–68.2 Gy (2.2 Gy per fraction). Both DA and RA plans were optimized in terms of dose coverage and constraints.

Results

Small differences between the techniques were observed for planning target volume (PTV) dose distribution, whereas significant differences in sparing of organs at risk (OARs) were recorded (p < 0.0001). The OAR values (median; 95 % confidence interval, CI) were: rectum: D30 % = 60.7 Gy (59.40–62.04 Gy) and 48.2 Gy (46.40–52.72 Gy), D60 % = 34.1 Gy (28.50–38.92 Gy) and 27.7 Gy (21.80–31.51 Gy); bladder: D30 % = 57.3 Gy (45.83–64.53 Gy) and 46.4 Gy (33.23–61.48 Gy), D50 % = 16.4 Gy (11.89–42.38 Gy) and 17.2 Gy (10.97–27.90 Gy), for DA and RA, respectively. Treatment times were very similar, whereas the monitor units (MU) were 550 ± 29 versus 277 ± 3 for RA and DA, respectively.

Conclusion

Dose–volume histograms (DVHs) show improvements in OAR sparing with RA. However, the RA technique is associated with almost double the number of MUs compared to DA. Regarding the PTV, DA is slightly superior in terms of D2 % and dose homogeneity. On the whole, the results suggest that RA be the favorable technique.
Literatur
1.
Zurück zum Zitat Alongi F, Fogliata A, Navarria P et al (2012) Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy by RapidArc for prostate. Strahlenther Onkol 188:990–996PubMedCrossRef Alongi F, Fogliata A, Navarria P et al (2012) Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy by RapidArc for prostate. Strahlenther Onkol 188:990–996PubMedCrossRef
2.
Zurück zum Zitat Aznar M, Petersen P, Logadottir A et al (2010) Rotational radiotherapy for prostate cancer in clinical practice. Radiother Oncol 97:480–484PubMedCrossRef Aznar M, Petersen P, Logadottir A et al (2010) Rotational radiotherapy for prostate cancer in clinical practice. Radiother Oncol 97:480–484PubMedCrossRef
3.
Zurück zum Zitat Bauman G, Rumble RB, Chen J et al (2012) Members of the IMRT indications expert panel. Intensity-modulated radiotherapy in the treatment of prostate cancer. Clin Oncol (R Coll Radiol) 24:461–473CrossRef Bauman G, Rumble RB, Chen J et al (2012) Members of the IMRT indications expert panel. Intensity-modulated radiotherapy in the treatment of prostate cancer. Clin Oncol (R Coll Radiol) 24:461–473CrossRef
4.
Zurück zum Zitat Bolla M, Poppel H van, Tombal B et al (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). The Lancet 380:2018–2027CrossRef Bolla M, Poppel H van, Tombal B et al (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). The Lancet 380:2018–2027CrossRef
5.
Zurück zum Zitat Bortfeld T, Webb S (2009) Single-Arc IMRT? Phys Med Biol 54:N9–N20 Bortfeld T, Webb S (2009) Single-Arc IMRT? Phys Med Biol 54:N9–N20
6.
Zurück zum Zitat Bottke D, Bartkowiak D, Schrader M, Wiegel T (2012) Radiotherapy after radical prostatectomy: immediate or early delayed? Strahlenther Onkol 188:1096–1101PubMedCrossRef Bottke D, Bartkowiak D, Schrader M, Wiegel T (2012) Radiotherapy after radical prostatectomy: immediate or early delayed? Strahlenther Onkol 188:1096–1101PubMedCrossRef
7.
Zurück zum Zitat Cambria R, Jereczek-Fossa BA, Cattani F et al (2009) Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use. Strahlenther Onkol 185:384–389PubMedCrossRef Cambria R, Jereczek-Fossa BA, Cattani F et al (2009) Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use. Strahlenther Onkol 185:384–389PubMedCrossRef
8.
Zurück zum Zitat Cambria R, Jereczek-Fossa BA, Zerini D et al (2011) Physical and clinical implication of the treatment with full bladder in the radiotherapy for the prostate cancer. Strahlenther Onkol 187:799–805PubMedCrossRef Cambria R, Jereczek-Fossa BA, Zerini D et al (2011) Physical and clinical implication of the treatment with full bladder in the radiotherapy for the prostate cancer. Strahlenther Onkol 187:799–805PubMedCrossRef
9.
Zurück zum Zitat Cozzi L, Dinshaw KA, Shrivastava SK et al (2008) A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 89:180–191PubMedCrossRef Cozzi L, Dinshaw KA, Shrivastava SK et al (2008) A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 89:180–191PubMedCrossRef
10.
Zurück zum Zitat Davidson MT, Blake SJ, Batchelar DL et al (2011) Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. Int J Radiat Oncol Biol Phys 80:1550–1558PubMedCrossRef Davidson MT, Blake SJ, Batchelar DL et al (2011) Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. Int J Radiat Oncol Biol Phys 80:1550–1558PubMedCrossRef
11.
Zurück zum Zitat Greco C, Mazzetta C, Cattani C et al (2003) Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. Radiother Oncol 69:215–222PubMedCrossRef Greco C, Mazzetta C, Cattani C et al (2003) Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. Radiother Oncol 69:215–222PubMedCrossRef
12.
Zurück zum Zitat Heemsbergen WD, Peeters ST, Koper PC et al (2006) Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys 66:3–10PubMedCrossRef Heemsbergen WD, Peeters ST, Koper PC et al (2006) Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys 66:3–10PubMedCrossRef
13.
Zurück zum Zitat Jereczek-Fossa BA, Cattani F, D’Onofrio A et al (2006) Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs). Radiother Oncol 81:294–302PubMedCrossRef Jereczek-Fossa BA, Cattani F, D’Onofrio A et al (2006) Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs). Radiother Oncol 81:294–302PubMedCrossRef
14.
Zurück zum Zitat Jereczek-Fossa BA, Vavassori A, Fodor C et al (2008) Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients. Int J Radiat Oncol Biol Phys 71:784–794PubMedCrossRef Jereczek-Fossa BA, Vavassori A, Fodor C et al (2008) Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients. Int J Radiat Oncol Biol Phys 71:784–794PubMedCrossRef
15.
Zurück zum Zitat Malone S, Croke J, Roustan-Delatour N et al (2012) Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT. Int J Radiat Oncol Biol Phys 84:725–732PubMedCrossRef Malone S, Croke J, Roustan-Delatour N et al (2012) Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT. Int J Radiat Oncol Biol Phys 84:725–732PubMedCrossRef
16.
Zurück zum Zitat Michalski JM, Gay H, Jackson A et al (2010) Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 76(3 Suppl):S123–S129PubMedCentralPubMedCrossRef Michalski JM, Gay H, Jackson A et al (2010) Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 76(3 Suppl):S123–S129PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Ost P, De Troyer B, Fonteyne V et al (2011) A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 80:1316–1322PubMedCrossRef Ost P, De Troyer B, Fonteyne V et al (2011) A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 80:1316–1322PubMedCrossRef
18.
19.
Zurück zum Zitat Pasler M, Wirtz H, Lutterbach J (2011) Impact of gantry rotation time on plan quality and dosimetric verification-volumetric modulated arc therapy (VMAT) vs. intensity modulated radiotherapy (IMRT). Strahlenther Onkol 187:812–819PubMedCrossRef Pasler M, Wirtz H, Lutterbach J (2011) Impact of gantry rotation time on plan quality and dosimetric verification-volumetric modulated arc therapy (VMAT) vs. intensity modulated radiotherapy (IMRT). Strahlenther Onkol 187:812–819PubMedCrossRef
20.
Zurück zum Zitat Patel P, Lee WR (2012) Radiotherapy following radical prostatectomy. Expert Rev Anticancer Ther 12:973–979PubMedCrossRef Patel P, Lee WR (2012) Radiotherapy following radical prostatectomy. Expert Rev Anticancer Ther 12:973–979PubMedCrossRef
21.
Zurück zum Zitat Pesce G, Clivio A, Cozzi L et al (2010) Early clinical experience of radiotherapy prostate cancer with volumetric modulated arc therapy. Radiat Oncol 5:54PubMedCentralPubMedCrossRef Pesce G, Clivio A, Cozzi L et al (2010) Early clinical experience of radiotherapy prostate cancer with volumetric modulated arc therapy. Radiat Oncol 5:54PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Poortmans P, Bossi A, Vandeputte K et al (2007) Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol 84:121–127PubMedCrossRef Poortmans P, Bossi A, Vandeputte K et al (2007) Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol 84:121–127PubMedCrossRef
23.
Zurück zum Zitat Quan EM, Li X, Li Y et al (2012) A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys 83:1169–1178PubMedCentralPubMedCrossRef Quan EM, Li X, Li Y et al (2012) A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys 83:1169–1178PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Rancati T, Fiorino C, Gagliardi G et al (2004) Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 73:21–32PubMedCrossRef Rancati T, Fiorino C, Gagliardi G et al (2004) Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 73:21–32PubMedCrossRef
25.
Zurück zum Zitat Siegmann A, Bottke D, Faehndrich J et al (2011) Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study. Strahlenther Onkol 187:467–472PubMedCrossRef Siegmann A, Bottke D, Faehndrich J et al (2011) Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study. Strahlenther Onkol 187:467–472PubMedCrossRef
26.
Zurück zum Zitat Thompson IM, Valicenti RK, Albertsen P et al (2013) Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO guideline. J Urol 190:441–449PubMedCrossRef Thompson IM, Valicenti RK, Albertsen P et al (2013) Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO guideline. J Urol 190:441–449PubMedCrossRef
27.
Zurück zum Zitat Valdagni R, Vavassori V, Rancati T et al (2012) Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial. Radiother Oncol 103:252–255PubMedCrossRef Valdagni R, Vavassori V, Rancati T et al (2012) Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial. Radiother Oncol 103:252–255PubMedCrossRef
28.
Zurück zum Zitat Viswanathan AN, Yorke ED, Marks LB et al (2010) Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 76(3 Suppl):S116–S122PubMedCentralPubMedCrossRef Viswanathan AN, Yorke ED, Marks LB et al (2010) Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 76(3 Suppl):S116–S122PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Wolff D, Stieler F, Welzel G et al (2009) Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 93:226–233PubMedCrossRef Wolff D, Stieler F, Welzel G et al (2009) Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 93:226–233PubMedCrossRef
30.
Zurück zum Zitat Zhang P, Happersett L, Hunt M et al (2010) Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys 76:1456–1462PubMedCrossRef Zhang P, Happersett L, Hunt M et al (2010) Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys 76:1456–1462PubMedCrossRef
Metadaten
Titel
Planning study to compare dynamic and rapid arc techniques for postprostatectomy radiotherapy of prostate cancer
verfasst von
Dr. R. Cambria, M.Sc.
F. Cattani
B.A. Jereczek-Fossa
F. Pansini
D. Ciardo
S. Vigorito
S. Russo
D. Zerini
L. Cozzi
R. Orecchia
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 6/2014
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0601-9

Weitere Artikel der Ausgabe 6/2014

Strahlentherapie und Onkologie 6/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.